Jaguar Health (JAGX) Sets New 52-Week Low at $0.36
Jaguar Health Inc (NASDAQ:JAGX)’s share price reached a new 52-week low during trading on Thursday . The stock traded as low as $0.36 and last traded at $0.35, with a volume of 44347 shares changing hands. The stock had previously closed at $0.43.
Separately, ValuEngine upgraded Jaguar Health from a “hold” rating to a “buy” rating in a research note on Thursday, November 1st.
The company has a quick ratio of 0.31, a current ratio of 0.46 and a debt-to-equity ratio of 1.03.
A hedge fund recently bought a new stake in Jaguar Health stock. Acadian Asset Management LLC bought a new position in shares of Jaguar Health Inc (NASDAQ:JAGX) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 99,557 shares of the biotechnology company’s stock, valued at approximately $141,000. Acadian Asset Management LLC owned approximately 1.14% of Jaguar Health at the end of the most recent reporting period. Institutional investors own 5.07% of the company’s stock.
About Jaguar Health (NASDAQ:JAGX)
Jaguar Health, Inc, a commercial stage natural-products pharmaceuticals company, focuses on developing gastrointestinal products for human prescription use and animals worldwide. The company, through its wholly-owned subsidiary, Napo Pharmaceuticals, Inc, focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas.
Further Reading: NASDAQ
Receive News & Ratings for Jaguar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Health and related companies with MarketBeat.com's FREE daily email newsletter.